Addressing the molecular heterogeneity of pancreatic cancer: personalised medicine in action.

解决胰腺癌的分子异质性：个性化医疗在行动。

• 批准号: nhmrc : GNT1162556
• 负责人: Dr Marina Pajic
• 金额: $ 48.34万
• 依托单位国家: 澳大利亚
• 项目类别: Career Development Fellowships
• 财政年份: 2019
• 资助国家: 澳大利亚
• 起止时间: 2019-01-01 至 无数据
• 项目状态: 已结题
• 来源: https://researchdata.edu.au/addressing-molecular-heterogeneity-medicine-action/1349362
• 关键词: Addressing; molecular; heterogeneity; pancreatic; cancer

My laboratory’s research builds on our discoveries in the field of cancer genomics where we have revealed the vast molecular diversity of pancreatic cancer. Our goal is to utilize this wealth of information to develop novel and effective personalised approaches for the treatment of pancreatic cancer, disease for which there are currently no curative systemic therapies.

我实验室的研究建立在我们在癌症基因组学领域的发现之上，我们揭示了胰腺癌巨大的分子多样性。我们的目标是利用这些丰富的信息来开发新颖且有效的个性化方法来治疗胰腺癌，目前尚无有效的全身疗法。